Medicare Enrolled
Dr. Sheetal Shah, D.O.
Family Medicine · Danville, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Sheetal Shah is a family medicine specialist in Danville, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 2,283 Medicare services across 1,902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $11,471 from 81 pharmaceutical and/or device companies across 609 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 9% volume in CA
$11,471 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,283
Medicare services
Top 9% in CA for family medicine
1,902
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
773 | $75 | $325 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $111 | $460 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
243 | $3 | $12 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
151 | $157 | $565 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
76 | $14 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
67 | $37 | $60 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
62 | $76 | $215 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
58 | $78 | $397 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
56 | $13 | $64 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
45 | $37 | $60 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
40 | $283 | $852 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
37 | $50 | $150 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
30 | $67 | $323 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
28 | $198 | $375 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $137 | $585 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
22 | $16 | $25 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
18 | $198 | $585 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
17 | $35 | $175 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
14 | $53 | $191 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
14 | $18 | $35 |
| Pap smear screening test A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis. |
13 | $56 | $250 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
12 | $66 | $260 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
11 | $16 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,471
Total received (2018-2024)
Avg $1,639/year across 7 years
Top 4% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
609
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,360 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$111 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,950
2023
$2,072
2022
$2,490
2021
$1,991
2020
$907
2019
$1,253
2018
$808
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$428
PFIZER INC.
$186
Novo Nordisk Inc
$120
AstraZeneca Pharmaceuticals LP
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$99
Bausch Health US, LLC
$98
Merck Sharp & Dohme LLC
$78
Sumitomo Pharma America, Inc.
$70
Otsuka America Pharmaceutical, Inc.
$63
Janssen Pharmaceuticals, Inc
$63
Lilly USA, LLC
$61
Novartis Pharmaceuticals Corporation
$55
Amgen Inc.
$49
Antares Pharma, Inc.
$44
Currax Pharmaceuticals LLC
$40
Lundbeck LLC
$40
Astellas Pharma US Inc
$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$29
GlaxoSmithKline, LLC.
$26
Vanda Pharmaceuticals Inc.
$26
Exact Sciences Corporation
$25
Abbott Laboratories
$24
Neurocrine Biosciences, Inc.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Corium, LLC
$21
Verity Pharmaceuticals Inc.
$19
Teva Pharmaceuticals USA, Inc.
$19
Indivior Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
Acella Pharmaceuticals, LLC
$17
Becton, Dickinson and Company
$17
Esperion Therapeutics, Inc.
$13
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$748
Amgen Inc.
$734
ABBVIE INC.
$644
AbbVie Inc.
$630
Boehringer Ingelheim Pharmaceuticals, Inc.
$539
Bausch Health US, LLC
$467
Otsuka America Pharmaceutical, Inc.
$442
Esperion Therapeutics, Inc.
$412
AstraZeneca Pharmaceuticals LP
$408
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$371
Novo Nordisk Inc
$315
Novartis Pharmaceuticals Corporation
$286
GlaxoSmithKline, LLC.
$285
Janssen Pharmaceuticals, Inc
$267
Teva Pharmaceuticals USA, Inc.
$266
Astellas Pharma US Inc
$252
Lilly USA, LLC
$221
Bayer HealthCare Pharmaceuticals Inc.
$219
Biohaven Pharmaceuticals, Inc.
$215
Regeneron Healthcare Solutions, Inc.
$210
Biohaven Pharmaceutical Holding Company Ltd.
$199
Allergan, Inc.
$191
Neurocrine Biosciences, Inc.
$159
Merck Sharp & Dohme LLC
$149
E.R. Squibb & Sons, L.L.C.
$141
ARBOR PHARMACEUTICALS, INC.
$138
Merck Sharp & Dohme Corporation
$129
Sumitomo Pharma America, Inc.
$114
Corium, LLC
$112
Takeda Pharmaceuticals U.S.A., Inc.
$104
Lundbeck LLC
$104
Alfasigma USA, Inc.
$97
Adlon Therapeutics L.P.
$93
Bayer Healthcare Pharmaceuticals Inc.
$90
Allergan Inc.
$69
ITI, Inc.
$67
Ironshore Pharmaceuticals Inc.
$66
Shire North American Group Inc
$64
Endo Pharmaceuticals Inc.
$64
Horizon Therapeutics plc
$57
Amarin Pharma Inc.
$57
Currax Pharmaceuticals LLC
$55
Nestle HealthCare Nutrition Inc.
$53
AbbVie, Inc.
$52
IBSA Pharma Inc.
$50
SANOFI PASTEUR INC.
$49
Abbott Laboratories
$49
Eisai Inc.
$48
Horizon Pharma plc
$48
Supernus Pharmaceuticals, Inc.
$45
Exact Sciences Corporation
$45
Antares Pharma, Inc.
$44
Alkermes, Inc.
$44
NESTLE HEALTHCARE NUTRITION INC.
$43
GENZYME CORPORATION
$39
SANOFI-AVENTIS U.S. LLC
$38
Kowa Pharmaceuticals America, Inc.
$38
Ultragenyx Pharmaceutical Inc.
$37
Daiichi Sankyo Inc.
$31
Almatica Pharma LLC
$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$29
Arbor Pharmaceuticals, Inc.
$28
kaleo, Inc.
$28
TherapeuticsMD, Inc.
$28
Impax Laboratories, Inc.
$27
Vanda Pharmaceuticals Inc.
$26
Tris Pharma Inc
$25
Assertio Therapeutics, Inc.
$24
Medtronic, Inc.
$21
Harmony Biosciences LLC
$19
Verity Pharmaceuticals Inc.
$19
Indivior Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
Acella Pharmaceuticals, LLC
$17
Becton, Dickinson and Company
$17
Medtronic USA, Inc.
$17
Greer Laboratories, Inc.
$16
EISAI INC.
$15
VBI Vaccine (Delaware) Inc.
$15
Scilex Pharmaceuticals Inc.
$14
Ironwood Pharmaceuticals, Inc
$14
Top 3 companies account for 18.5% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AJOVY · ANNOVERA · APLENZIN · ARISTADA · AUSTEDO · AUVI-Q · AZSTARYS · Aimovig · AirDuo Digihaler · ArmonAir Digihaler · Austedo XR · Azstarys · BELSOMRA · BREZTRI · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD · CONTRAVE · CREON · Cambia · Cologuard Collection Kit · Creon · Cryvista · DUPIXENT · Dayvigo · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · Edarbi · Edarbyclor · FANAPT · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUMIST QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GEMTESA · GLYXAMBI · GRALISE · Horizant · INGREZZA · INJECTAFER · INTERSTIM · JANUVIA · JARDIANCE · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · LEQVIO · LILETTA · LINZESS · LOREEV XR · LUPRON DEPOT · LYRICA · Linzess · Lupron · MENQUADFI · MIGRANAL · MOUNJARO · MYRBETRIQ · Myrbetriq · NASCOBAL · NEXLETOL · NP Thyroid 60 · NURTEC ODT · ONGENTYS · ORALAIR · OXTELLAR XR · Otezla · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QELBREE · QULIPTA · RELISTOR · REXULTI · RYBELSUS · RYTARY · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SUBLOCADE · SYMBICORT · SYNTHROID · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tlando · Tresiba · UBRELVY · VENASEAL · VIIBRYD · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Vivitrol · WAKIX · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XIFIXAN · XYOSTED · ZENPEP · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,006
Per 100K population
86.6
County median income
$125,727
Nearest hospital
STANFORD HEALTH CARE TRI-VALLEY
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shah performed 773 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $11,471 from 81 companies across 609 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other family medicine physicians in Danville?
Dr. Shah's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Danville
Browse family medicine physicians in Danville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology